PolyPeptide Group AG Logo

PolyPeptide Group AG

ISIN: CH1110760852 | Ticker: PPGN | LEI: 5067007JCKTPOX4G9758
Sector: Health CareSub-Industry: Health Care Supplies
Country: Switzerland

About PolyPeptide Group AG

Company Description

PolyPeptide Group is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used in approved pharmaceutical products, drugs in clinical development as well as in generic products.

Dating back to 1952, PolyPeptide today manufactures around one-half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with around 1,100 employees at the end of 2021, its diversity brings breadth, depth of knowledge and experience to the group.

PolyPeptide has grown organically and by selective acquisition of existing expertise, culminating in its position today as a leader in outsourced peptide manufacturing.

Served area





Dammstrasse 19, 6300 Zug – Switzerland

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
10.11.23 None Executive member Buy CHF 51,250.00
11.10.23 None Executive member Buy CHF 2,876,348.62
10.10.23 None Executive member Buy CHF 371,202.96
26.04.22 None Non-Executive member Buy CHF 90,000.00
26.04.22 None Non-Executive member Buy CHF 70,000.00
26.04.22 None Non-Executive member Buy CHF 50,000.00
26.04.22 None Non-Executive member Buy CHF 45,000.00

Capital markets information






Health Care

Industry Group

Health Care Equipment & Services


Health Care Equipment & Supplies


Health Care Supplies

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.